Revenue Estimates Analysis: Corcept Therapeutics Incorporated (NASDAQ:CORT)


Corcept Therapeutics Incorporated (NASDAQ:CORT) will report its next earnings on Feb 27 – Mar 3 (Est.). The company reported the earnings of $0.02/Share in the last quarter where the estimated EPS by analysts was $0.01/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 100%.

Many analysts are providing their Estimated Earnings analysis for Corcept Therapeutics Incorporated and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.02/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0.03/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Corcept Therapeutics Incorporated as 23.38 Million. According to these analysts, the Low Revenue Estimate for Corcept Therapeutics Incorporated is 22.92 Million and the High Revenue Estimate is 23.9 Million. The company had Year Ago Sales of 14.97 Million.

Some buy side analysts are also providing their Analysis on Corcept Therapeutics Incorporated, where 2 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 0 said it’s a HOLD, 1 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for Corcept Therapeutics Incorporated might touch $12 high while the Average Price Target and Low price Target is $11.67 and $11 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Corcept Therapeutics Incorporated got Initiated on 21-Apr-15 where investment firm FBR Capital Initiated the stock to Outperform.

Corcept Therapeutics Incorporated closed its last trading session at $9.09 with the loss of -7.26%. The Market Capitalization of the company stands at 935.98 Million. The Company has 52-week high of $10 and 52-week low of $3.22. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -3.21% where SMA50 and SMA200 are 13.48% and 47.53% respectively. The Company Touched its 52-Week High on Nov 14, 2016 and 52-Week Low on Jan 28, 2016.

The Relative Volume of the company is 3.35 and Average Volume (3 months) is 532.13 million. Corcept Therapeutics Incorporated P/E (price to earnings) ratio is 216.15 and Forward P/E ratio of 32.67.

The company shows its Return on Assets (ROA) value of 8%. The Return on Equity (ROE) value stands at 18.8%. While it’s Return on Investment (ROI) value is -7.5%.

While looking at the Stock’s Performance, Corcept Therapeutics Incorporated currently shows a Weekly Performance of -9.84%, where Monthly Performance is 22%, Quarterly performance is 55.82%, 6 Months performance is 40.03% and yearly performance percentage is 59.66%. Year to Date performance value (YTD perf) value is 69.28%. The Stock currently has a Weekly Volatility of 5.49% and Monthly Volatility of 5.24%.